(Q69745714)
Statements
Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route (English)
Dowsett M
Goss PE
Powles TJ
Hutchinson G
Brodie AM
Jeffcoate SL
scientific article published on 01 April 1987